Othus, M., Kantarjian, H. M., Petersdorf, S., Ravandi, F., Cortes, J. E., Pierce, S. A., … Estey, E. H. (2012). Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given “Intensive” Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA). In Blood (Vol. 120, pp. 129–129). American Society of Hematology. https://doi.org/10.1182/blood.v120.21.129.129

Othus, Megan, Hagop M. Kantarjian, Stephen Petersdorf, Farhad Ravandi, Jorge E. Cortes, Sherry A. Pierce, Harry Paul Erba, Stefan Faderl, Frederick R. Appelbaum, and Elihu H. Estey. “Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given “Intensive” Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA).” In Blood, 120:129–129. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.129.129.

Othus M, Kantarjian HM, Petersdorf S, Ravandi F, Cortes JE, Pierce SA, et al. Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given “Intensive” Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA). In: Blood. American Society of Hematology; 2012. p. 129–129.

Othus, Megan, et al. “Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given “Intensive” Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA).” Blood, vol. 120, no. 21, American Society of Hematology, 2012, pp. 129–129. Crossref, doi:10.1182/blood.v120.21.129.129.

Othus M, Kantarjian HM, Petersdorf S, Ravandi F, Cortes JE, Pierce SA, Erba HP, Faderl S, Appelbaum FR, Estey EH. Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given “Intensive” Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA). Blood. American Society of Hematology; 2012. p. 129–129.